Mechanisms for Laser-Induced Rejuvenation in Skin Cancer Risk Reduction
Official title: Mechanisms for Laser-Induced Rejuvenation
Run by Wright State University · NCT06489301 · Data updated 2026-11-12
This study tests whether cells called fibroblasts that appear after Fractionated Laser Resurfacing can be traced to their origin in people planning abdominoplasty.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Wright State University Academic / other |
| Locations | 1 site (Fairborn, Ohio) |
| Status | Recruiting |
| Started | July 16, 2025 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT06489301 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older planning to undergo abdominoplasty with at least 50 x 20 cm of skin to be removed.
✕Probably not a fit
Patients not undergoing abdominoplasty or with exclusionary health conditions may not experience a direct benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers are investigating how Fractionated Laser Resurfacing after aging skin affects a population at risk for skin cancer, aiming to identify the cellular source of youth-like UVB responses seen after treatment. The study enrolls adults undergoing abdominoplasty to collect tissue samples and study fibroblast origins following laser treatment. Methods involve observing post-laser tissue changes and analyzing cell lineage in collaboration with the university’s pharmacology translational unit. The trial is interventional but does not specify a traditional randomization or control group.
Why it matters
Potential benefit: If successful, the findings could clarify how laser treatment influences skin cell behavior and potentially improve strategies to reduce skin cancer risk.
How similar studies have gone: Previous work with laser-induced skin changes has shown measurable cellular responses, but this study focuses on origin tracing of fibroblasts, making its approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult males and females 18 and older * Able to comprehend procedures and risks * Planning to undergo abdominoplasty surgery * Minimum amount of skin to be removed is 50 x 20cm Exclusion Criteria: * Medical history of not well-controlled diabetes. This is defined as a subject who needs high doses of insulin, recent history of hospitalization for diabetes-related complications, or poor wound health as evidenced by diabetic ulcers. Subjects who have been deemed healthy enough for abdominoplasty surgery would tend to suggest that their diabetes should not be an issue. However, if the subjects have diabetic complications as outlined above, they could affect the wound healing which is the object of this protocol so they would be excluded. * Pregnant or nursing * History of pathologically abnormal wound healing such as keloidal scars * Existing tattoos on the abdomen that are so extensive that they could interfere with the study
Where it's running
-
Pharmacology Translational Unit
Fairborn, Ohio, United States Recruiting
Study contacts
- Principal investigator: Jeffrey Travers, MD, PhD — Wright State University
- Study coordinator: Manager, Clinical Research Operations
- Email: pturesearch@wrightstatephysicians.org
- Phone: 937-245-7500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile sun protection support to help young adults stay safe in the sun
This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.
-
Psycho-physiological profiling of people with low versus high heat resilience
This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.
-
Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers
This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.
-
First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia
This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.
-
Optical and multi-modal analysis to help diagnose skin cancer
This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.
-
Early skin tumor detection with telemedicine in primary care
This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.